We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$939M
AUM Growth
+$44.4M
Cap. Flow
+$13.7M
Cap. Flow %
1.46%
Top 10 Hldgs %
22.25%
Holding
284
New
15
Increased
111
Reduced
114
Closed
3

Top Buys

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$11.7M
2
CACI icon
CACI
CACI
+$3.33M
3
AMGN icon
Amgen
AMGN
+$1.22M
4
COST icon
Costco
COST
+$719K
5
EVH icon
Evolent Health
EVH
+$480K

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.16%
2 Healthcare 13.64%
3 Consumer Staples 12.47%
4 Financials 11.93%
5 Technology 11.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWD icon
251
iShares Russell 1000 Value ETF
IWD
$84.3B
$236K 0.03%
2,049
EA
252
DELISTED
Electronic Arts
EA
$234K 0.02%
+2,615
New +$223K
NSC icon
253
Norfolk Southern
NSC
$78.3B
$233K 0.02%
2,081
WOR icon
254
Worthington Enterprises
WOR
$2.8B
$232K 0.02%
8,360
NEE icon
255
NextEra Energy
NEE
$171B
$228K 0.02%
7,116
+36
+0.5% +$1.13K
IYE icon
256
iShares US Energy ETF
IYE
$1.83B
$227K 0.02%
5,884
NVS icon
257
Novartis
NVS
$292B
$227K 0.02%
+3,407
New +$227K
BEN icon
258
Franklin Templeton
BEN
$17.6B
$226K 0.02%
5,368
-150
-3% -$6.22K
ADNT icon
259
Adient
ADNT
$1.47B
$224K 0.02%
+3,078
New +$202K
HSY icon
260
Hershey
HSY
$36B
$220K 0.02%
+2,017
New +$216K
CVGW
261
DELISTED
Calavo Growers
CVGW
$217K 0.02%
3,575
-845
-19% -$48.7K
SHPG
262
DELISTED
Shire pic
SHPG
$210K 0.02%
1,205
-574
-32% -$100K
NUVA
263
DELISTED
NuVasive, Inc.
NUVA
$205K 0.02%
+2,748
New +$199K
IJK icon
264
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$204K 0.02%
+4,264
New +$201K
CHTR icon
265
Charter Communications
CHTR
$18.3B
$203K 0.02%
+619
New +$197K
BIO icon
266
Bio-Rad Laboratories Class A
BIO
$10.4B
$201K 0.02%
+1,010
New +$195K
DYSL
267
DELISTED
Dynasil Corporation of America
DYSL
$172K 0.02%
136,260
+4,883
+4% +$6.24K
LQMT
268
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
$41K ﹤0.01%
213,000
ATNM icon
269
Actinium Pharmaceuticals
ATNM
$31.7M
$35K ﹤0.01%
762
TNDM icon
270
Tandem Diabetes Care
TNDM
$1.49B
$21K ﹤0.01%
1,757
RGLS
271
DELISTED
Regulus Therapeutics
RGLS
$19K ﹤0.01%
+96
New +$18.3K
NSIT icon
272
Insight Enterprises
NSIT
$4.57B
-5,756
Closed -$233K
LINE
273
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
-11,875
Closed -$1K

Similar funds

Dowling & Yahnke's Q1 2017 Portfolio in Review

As of Q1 2017, Dowling & Yahnke held 284 positions worth $939M, up 5% from $894M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Dowling & Yahnke's Q1 2017 filing shows 15 new, 111 increased, 114 reduced and 3 closed positions. Its largest new stake was Raytheon Company: 77,670 shares worth $11.8M. The largest sale was Reliance Steel & Aluminium, an estimated $2.44M.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dowling & Yahnke's largest Q1 2017 buy was Raytheon Company: 77,670 shares worth $11.8M.
  • Dowling & Yahnke added most to Amgen in Q1 2017, an estimated $1.22M increase.
  • Dowling & Yahnke's biggest Q1 2017 reduction was Reliance Steel & Aluminium, cutting an estimated $2.44M.
  • Dowling & Yahnke fully exited Insight Enterprises in Q1 2017, selling an estimated $233K.
  • Dowling & Yahnke's ten largest holdings make up 22% of its $939M portfolio in Q1 2017.
  • Dowling & Yahnke opened 15 new positions and closed 3 in Q1 2017.
  • Dowling & Yahnke's portfolio value rose 5% quarter-over-quarter to $939M.

Based on Dowling & Yahnke's 13F filing for Q1 2017, filed 27 Apr 2017.